Trulieve Cannabis (TRLV) Other Operating Expenses (2020 - 2026)

Trulieve Cannabis has reported Other Operating Expenses for 7 years, with the latest figure at $431.0 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses rose 1377.4% year-over-year to $431.0 million in Q2 2026; TTM through Jun 2026 was $522.7 million, a 2551.54% increase from a year earlier, with the FY2025 full-year figure at $69.4 million, up 134.41% from the prior year.
• Other Operating Expenses was $431.0 million for Q2 2026 at Trulieve Cannabis, up from $29.5 million in the prior quarter.
• The five-year high for Other Operating Expenses was $431.0 million in Q2 2026, with the low at -$229.6 million in Q4 2023.
• Average Other Operating Expenses over 5 years is $34.8 million, with a median of $9.8 million recorded in 2023.
• The largest YoY upside for Other Operating Expenses was 46963.98% in 2023 against a maximum downside of 5380.84% in 2023.
• Over 5 years, Other Operating Expenses stood at $4.3 million in 2022, then sank by 5380.84% to -$229.6 million in 2023, then surged by 83.05% to -$38.9 million in 2024, then soared by 186.22% to $33.6 million in 2025, then jumped by 1184.29% to $431.0 million in 2026.
• The last three Other Operating Expenses figures came in at $431.0 million (Q2 2026), $29.5 million (Q1 2026), and $33.6 million (Q4 2025), per Business Quant data.